Intellectual property
The patent application for TL-532 and a new family of TLR3 ligands was filed by TOLLYS in 2018 (EP 18305561).
Tollys
A new dimension in immuno-oncology
Office
41 quai Fulchiron
69005 Lyon, FRANCE
The patent application for TL-532 and a new family of TLR3 ligands was filed by TOLLYS in 2018 (EP 18305561).
A new dimension in immuno-oncology
41 quai Fulchiron
69005 Lyon, FRANCE